(Press-News.org) One decade after receiving implants that stimulate areas of their brains, patients with Parkinson's disease (PD) appear to sustain improvement in motor function, although part of the initial benefit wore off mainly because of progressive loss of benefit in other functions, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals.
According to background information in the article, several previous clinical studies have shown deep brain stimulation of the subthalamic nucleus (STN-DBS) for PD to be effective and safe. Studies have shown that the technique, which stimulates a part of the brain involved in motor function, may have advantages compared with other medical treatments in terms of controlling motor complications and improving quality of life. "The motor improvement induced by STN stimulation has been reported to be sustained for up to five to eight years after surgery, although part of the initial benefit progressively deteriorates, mainly because of worsening axial signs," write the authors. "To date, studies with postoperative follow-up for longer than eight years are lacking."
Anna Castrioto, M.D., from the Università degli Studi di Perugia, Perugia, Italy, and colleagues conducted a study of 18 patients with advanced PD who had received DBS implants for PD between 1996 and 2000. Motor assessments were conducted before implantation and at one, five and 10 years. All motor assessments were videotaped. Patients were assessed without medication, without stimulation, without either, and with both. At each assessment, the researchers recorded every patient's medications and dosages.
At 10 years, the combination of medication and STN-DBS was associated with significantly better motor, resting and action tremor, bradykinesia (slowed movement) and rigidity scores. Compared with baseline, reductions were also seen in the scores in the medication and no medication conditions, the dyskinesia (difficulty controlling movement) and motor fluctuation scores and the levadopa-equivalent daily dose. However, axial signs (such as posture, gait and balance) showed the most progressive decline in stimulation and medication response.
"Our findings further support the long-term response to STN stimulation in patients with advanced PD, showing a prolonged motor improvement up to 10 years," conclude the authors.
###
(Arch Neurol. Published August 8, 2011. doi:10.1001/archneurol.2011.182. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact Elena Moro, M.D., Ph.D., call Nadia Daniell-Colarossi at 416-603-5294 or e-mail nadia.daniell-colarossi@uhn.ca.
Deep brain stimulation effects may last for 10 years in patients with Parkinson's disease
2011-08-09
ELSE PRESS RELEASES FROM THIS DATE:
Women more likely to recruit other women for political office
2011-08-09
Los Angeles, CA (DATE) The gender composition of those responsible for candidate recruitment plays a crucial role in either encouraging or discouraging women candidates to run for office, according to a recent study in Political Research Quarterly (PRQ) published by SAGE on behalf of the Western Political Science Association.
"Researchers Christine Cheng and Margit Tavits looked at "party gatekeepers" (local party presidents) from the five major political parties in the 2004 and 2006 Canadian national elections. Unlike the US, the nomination of party candidates for the ...
Age and severity of heart failure associated with impairment in verbal memory
2011-08-09
Older patients with lower rates of left ventricular ejection fraction (a measure of how well the left ventricle of the heart pumps with each contraction) appear more likely than younger patients to have significantly reduced verbal memory function, according to a report in the August issue of Archives of Neurology, one of the JAMA/Archives journals.
Three decades ago, researchers began investigating the association of heart failure with cognitive decline, according to background information in the article. Thirty to 80 percent of patients with heart failure may experience ...
Blood loss from lab testing associated with hospital-acquired anemia for patients with heart attacks
2011-08-09
In patients with acute myocardial infarction (heart attack), blood loss from greater use of phlebotomy (blood drawn for diagnostic testing) appears to be independently associated with the development of hospital-acquired anemia (HAA), according to a report published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal's Less Is More series.
Anemia (low red blood cell count or low hemoglobin level) is associated with greater mortality and worse health status in patients with AMI, whether the condition is chronic ...
Researchers develop risk assessment model for advanced age-related macular degeneration
2011-08-09
A new risk assessment model may help predict development of advanced age-related macular degeneration, according to a report published Online First by Archives of Ophthalmology, one of the JAMA/Archives journals.
Age-related macular degeneration (AMD) is a leading cause of blindness in the United States and the Western world, according to background information in the article. "As progress in designing better preventive measures and earlier treatment options accelerates and new gene associations are identified that add to currently known risk factors, the desirability ...
More frequent visual field testing may lead to earlier detection of glaucoma progression
2011-08-09
In patients with glaucoma, frequent visual field testing may be associated with earlier detection of the condition's progression, according to a report published Online First by Archives of Ophthalmology, one of the JAMA/Archives journals.
According to background information in the article, visual field testing is one of the main ways of monitoring patients with glaucoma for progression. "Estimating rates of progression can help identify patients who are progressing at a faster pace and are therefore at serious risk of developing visual disability during their lifetime," ...
Soy tablets not associated with reduction in bone loss or menopausal symptoms in women
2011-08-09
Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the August 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
The beginning stages of menopause are often accompanied by rapid bone loss, hot flashes, vaginal dryness and sleep disturbances among other symptoms, according to background information in the article. "Estrogen therapy with or without progesterone prevents most of these changes. However, as a result of ...
Massachusetts health-care reform associated with increased demand for medical safety-net facilities
2011-08-09
Patient demand for care from safety-net providers (such as community health centers and public hospitals) in Massachusetts has increased, even though the number of patients with health insurance also increased following the state's passage of health care reform, according to a report in the August 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal's Health Care Reform series.
According to background information in the article, a disproportionate share of patients who do not have health insurance obtain care ...
Newly discovered antibody recognizes many strains of flu virus
2011-08-09
Some vaccines are once-in-a-lifetime; others need a booster shot or two to maintain their potency. And then there's the flu vaccine, which only lasts a year. Strains of influenza virus change so much from year-to-year that new vaccines must be developed annually to target the strains of virus that are most likely to cause illness. But Howard Hughes Medical Institute (HHMI) scientists have now discovered a human antibody that recognizes many different flu strains. Understanding more about this antibody may help scientists design a longer-lasting vaccine against the influenza ...
Meteorites: Tool kits for creating life on Earth
2011-08-09
Washington, D.C.—Meteorites hold a record of the chemicals that existed in the early Solar System and that may have been a crucial source of the organic compounds that gave rise to life on Earth. Since the 1960s, scientists have been trying to find proof that nucleobases, the building blocks of our genetic material, came to Earth on meteorites. New research, published next week in the Proceedings of the National Academy of Sciences, indicates that certain nucleobases do reach the Earth from extraterrestrial sources, by way of certain meteorites, and in greater diversity ...
Biology, materials science get a boost from robust imaging tool
2011-08-09
EUGENE, Ore. -- (Aug. 8, 2011) -- Shape and alignment are everything. How nanometer-sized pieces fit together into a whole structure determines how well a living cell or an artificially fabricated device performs. A new method to help understand and predict such structure has arrived with the successful use a new imaging tool.
Coupling laser-driven, two-dimensional fluorescence imaging and high-performance computer modeling, a six-member team -- led by University of Oregon chemist Andrew H. Marcus and Harvard University chemist Alan Aspuru-Guzik -- solved the conformation ...